Diya Garg

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Effects of biological therapies on patients with Type-2 high asthma and comorbid obesity”.

Effects of biological therapies on patients with Type-2 high asthma and comorbid obesity

Frontiers in Pharmacology(2024)10.3389/fphar.2023.1315540

N/A

0DataRank · unranked

13 citations

Loretta G. Que, Jennifer L. Ingram, Diya Garg

First-Line Ipilimumab with Nivolumab versus Immune Checkpoint Inhibitors with Tyrosine Kinase Inhibitors in Patients with Intermediate- or Poor-Risk Metastatic Clear Cell Renal Cell Carcinoma

Journal of Kidney Cancer and VHL(2025)10.15586/jkcvhl.v12i2.387

N/A

0DataRank · unranked

3 citations

Yeonjung Jo, Georges Gebrael, Chadi Hage Chehade, Zeynep İrem Özay, Blake Nordblad +11 more

Neuromuscular junction transcriptome analysis of spinal and bulbar muscular atrophy mice implicates sarcomere gene expression and calcium flux dysregulation in disease pathogenesis

Human Molecular Genetics(2025)10.1093/hmg/ddaf074

N/A

0DataRank · unranked

1 citations

Byeonggu Cha, Nhat Nguyen, Diya Garg, Connor Coscolluela, Laura M. Strickland +6 more